Lunai Bioworks Inc. Common Stock

$2.410
USD
Last updated on --.
24h volume37.65K
24h highest2.5500 USD
24h lowest2.3900 USD
24h Price movement+0.00%

LNAI recent prices

24 Hours
+0.00%$0.00
30 days
-18.03%-$0.53
60 days
+6.64%+$0.15
90 days
-6.99%-$0.1812

Key data

Previous close2.4100 USD
Market cap9.16M USD
Volume37.65K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-28.2900 USD
Net income (FY)-128.28M USD
Revenue (FY)20.94K USD
Last report dateMay 15, 2026

About Lunai Bioworks Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersSUITE 906 LOS ANGELES
Employees (FY)29.00
Revenue per employee (FY)722.14 USD
Net income per employee (FY)-4.42M USD
Listed onNasdaq
Official website

LNAI conversion tables

LNAILNAI
USDUSD
0.5 LNAI1.205 USD
1 LNAI2.410 USD
5 LNAI12.05 USD
10 LNAI24.1 USD
USDUSD
LNAILNAI
0.5 USD0.20747 LNAI
1 USD0.41494 LNAI
5 USD2.074 LNAI
10 USD4.149 LNAI

FAQ

LNAI is trading at $2.410, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LNAI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LNAI is currently trading at $2.410, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LNAI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LNAI's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LNAI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LNAI's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lunai Bioworks Inc. Common Stock's market cap is currently 9.16M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume37.65K
24h highest2.5500 USD
24h lowest2.3900 USD
24h Price movement+0.00%
LNAILNAI
USDUSD
Start trade with LNAI Perpetual